Elixinol Australia was founded in 2014 to participate in the emerging Australian medicinal cannabis market. The Company submitted license applications for cultivation and manufacture to the Office of Drug Control in early 2018 and these applications are currently pending approval.
Whilst awaiting the granting of these licenses, Elixinol Australia has been advancing its plans for the development of an integrated cultivation and manufacturing facility in order to produce medicinal cannabis products to service Australian demand and to access export opportunities.
Elixinol Australia plans to leverage decades of expertise in industrial hemp and its derivatives (whole plant CBD/THC extracts), product formulation and delivery systems to become a leading provider of safe, stable and effective medicinal cannabis products.
Elixinol Australia website